Department of Medicine - Faculty of Medicine and Health Sciences

Dr. Susan Kahn Receives 2026 CSCI Distinguished Scientist Award

ada.prunescu@mcgill.ca — Thu, 21 May 2026 15:30:25 +0000

Congratulations to Dr. Susan Kahn on receiving the 2026 Distinguished Scientist Award from the Canadian Society for Clinical Investigation (CSCI) during the CSCI–CITAC–CIP Annual Joint Meeting in Toronto this April. The national award recognizes Canadian MD or PhD medical scientists who have made significant contributions to new knowledge and are recognized as leaders and innovators at the forefront of research in their field.

2026-2027 FRQS Results

ada.prunescu@mcgill.ca — Fri, 01 May 2026 23:40:09 +0000

A strong showing in this year’s FRQS competition. The DOM achieved an 85% success rate, with 11 of 13 applicants funded.

Across Quebec, 52% of career awards were funded (137/262). The DOM accounted for 8% of these awards, a strong contribution for a single department within one of 10 universities funded. Notably, one of just four Chercheur(e) de mérite career awards across Québec went to Dr. Donald Vinh from our Division of Infectious Diseases.

Dr. Atul Verma Receives the Wilton Wells Webster Award

ada.prunescu@mcgill.ca — Fri, 01 May 2026 23:38:33 +0000

Congratulations to Dr. Atul Verma on receiving the Wilton Wells Webster Award at the recent Heart Rhythm Society meeting in Chicago. This prestigious award recognizes the top international researcher in heart rhythm disorders and is typically awarded to individuals later in their careers, making this a notable mid-career achievement.

Dr. Emilie Trinh Named Young Nephrologist of the Year

ada.prunescu@mcgill.ca — Fri, 24 Apr 2026 17:43:55 +0000

We are pleased to share that Dr. Emilie Trinh has been named Young Nephrologist of the Year by the Société Québécoise de Néphrologie (SQN). This award recognizes a promising early-career nephrologist for contributions to community involvement, academic work, or education.

Dr. Trinh was recognized for her work in quality improvement, research, and education. This also marks the second consecutive year that a 91ɬ�� nephrologist has received this award, following Dr. Thomas Mavrakanas in 2025.

Dr. Elvin Kedhi Appointed 91ɬ�� DOM Director of Fellowships

ada.prunescu@mcgill.ca — Fri, 24 Apr 2026 17:37:17 +0000

We are pleased to announce the appointment of Dr. Elvin Kedhi to the new position of 91ɬ�� DOM Director of Fellowships. Dr. Kedhi is Professor of Medicine and Director of Interventional Cardiology at the MUHC, and Director of the 91ɬ�� Complex High-Risk Indicated Percutaneous Coronary Intervention (CHIP-PCI) Fellowship.

Making Space in Science: Eleanor Hill Venning

ada.prunescu@mcgill.ca — Fri, 13 Mar 2026 18:23:33 +0000

With International Women’s Day recently marked on March 8, we take this opportunity to highlight a pioneer from our department’s history: Eleanor Hill Venning, a Montreal-born chemist whose work changed how we understand hormones and their role in health and pregnancy. In the 1930s, Venning developed new ways to measure hormone byproducts in urine, making it possible for scientists and clinicians to study reproductive biology with a precision that had not existed before.

In Memoriam: Dr. Robert Sladek

David Langlais, Ken Dewar, Alexander DeGuise and William Foulkes — Fri, 13 Mar 2026 18:20:06 +0000

Dr. Robert Sladek was an exceptional scientist, mentor, colleague, and friend whose passing leaves a profound void in our community. He died in the early hours of March 3, 2026.

Venous Thrombosis Trial Published in The New England Journal of Medicine

Ottawa Hospital Research Institute — Fri, 13 Mar 2026 18:18:19 +0000

The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban is safer than rivaroxaban, with fewer bleeding complications.

The COBRRA trial, led by researchers at The Ottawa Hospital, aimed to directly compare bleeding with apixaban and rivaroxaban in venous thrombosis patients. The trial enrolled 2,760 participants from 32 sites across Canada, Australia and Ireland.

Dr. Susan Kahn honoured for a lifetime of achievement in thrombosis medicine

ada.prunescu@mcgill.ca — Fri, 27 Feb 2026 17:02:57 +0000

Dr. Susan Kahn, Professor of Medicine at 91ɬ�� and Director of the Centre of Excellence in Thrombosis and Anticoagulation Care at the Jewish General Hospital, has been named a recipient of the 2026 Esteemed Career Award from the International Society on Thrombosis and Haemostasis. She will receive the award this July at the ISTH Congress in Paris.

Department of Medicine Members Awarded New CIHR Project Grants

Dr. Kevin Schwartzman, Associate Chair of Research, 91ɬ�� Department of Medicine — Wed, 11 Feb 2026 19:14:43 +0000

The DOM is delighted to share our colleagues’ successes at the Fall 2025 CIHR Project Grant competition. Results just announced by CIHR include new multi-year project grants to nominated principal investigators Drs. Amine Benmassaoud, Jonathon Campbell, Maziar Divangahi, Emily McDonald, Sushmita Pamidi, Marc Rodger, Bryan Ross, Erwin Schurr, and Peter Siegel. Their projects represent a total of $10.5 million in new CIHR funding. They highlight the diverse research strengths of our department, and the promise of our newest investigators. Congratulations to all!